OCSL Q1 2026 Earnings EPS Surpasses Estimates as Portfolio Remains Resilient OSBC Q1 2026 Earnings EPS Misses Estimates as Shares Edge Higher AVTX Q1 2026 Earnings Narrowed Loss Meets Expectations Amid Strategic Pivot CRISPR Therapeutics Q1 2026 Earnings Slight EPS Miss as Clinical Pipeline Progresses MTDR Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response Nyxoah SA Q1 2026 Earnings NarrowerThanExpected Loss on Operational Discipline